Liztox 200 Unit
Botulinum Toxin Type A
Composition
Clostridium Botulinum Toxin Type A
Ingredients
200 units Clostridium botulinum toxin type A
0.5mg Human Serum Albumin
0.9mg Sodium chloride
Storage Method
Store refrigerated at temperature between 2-8°C
Injection Depth
Muscle Layer
Application Areas
Inject on facial areas with wrinkles
Maintenance Period
6~12 month
Liztox 200U
Liztox® is an innovative myorelaxant from the largest South Korean pharmaceutical concern, Huons Global Co., Ltd. The type A botulinum toxin in the product composition provides effective skin flattering through the smoothing of middle-to-deep wrinkles. High degree of product purification promotes fast metabolism of compounds in the body and the aesthetic effect of injections comes to the utmost short term.
Liztox® is a highly-purified clostridium botulinum toxin type A for correction and preventive care of mimic wrinkles. Due to inhibition of signaling between muscles and motor nerves, the product acts as a myorelaxant and is used for the control of dynamic wrinkles. The levelling effect of Liztox is reached by the correction of both, small and deep wrinkles. Applying regularly, the product effectively prevents formation of new folds. In addition, Liztox may be used for the treatment of increased diaphoresis via injections at the perspiratory gland localization (palms, axillas, footsteps). The apparent benefit is the local effect of the drug at the injection area that allows to correct cosmetical defects or provide a treatment (at hyperhydrosis) pointwise, without any side effects on the whole body.
Liztox® 200U benefits:
- high degree of product purification (99.8%),
- very quickly metabolized by the body, so the effect is visible even 3-7 days after the treatment,
- product safety which eliminates side effects,
- using the micro-papule technique, the product can be used to correct mimic wrinkles around the mouth.
How to administer Liztox 200 U
To address glabellar lines (forehead wrinkles): Using a 30 gauge needle, inject the dissolved product in the corrugator muscles and the procerus muscle (a total of 5 areas). 0.1ml of the product should be injected in each area, with a total of 20 U being injected.
When injecting into the inner corrugator supercilii muscle and the medial eyebrows, inject at least 1 cm from the edge of the eye. During injection, the needle should be aimed at the upper center, and the injection volume should be accurate. Careful attention should be paid to NOT inject Liztox 200 U into the blood vessel. To prevent Liztox 200 U from being injected into the blood vessel(exudation) below the orbital ridge, place the thumb or index finger below the orbital ridge prior to injection.
The corrugator muscle and the orbicularis oculi muscle move in the middle of the forehead to make glabellar folds on the face. The procerus muscle and the depressor supercilii muscle pull the forehead downward. These muscles create frown lines or wrinkles. Because the muscle position, muscle size, and use of muscle vary from person to person, the effective dose is determined by complete observation of the patient's ability to control the implanted surface muscles.
To address wrinkles around the eyes: Using a 30~33 gauge needle, administer 0.1ml(4U) each on 3 areas on one of the outer regions of the orbicularis oculi muscles (6 areas on both sides, total of 24 U).
To treat blepharospasm: Blepharospasm is defined as the uncontrollable muscle movements of the eyelid. Liztox 200 Unit should be administered using a sterile, 27-30 gauge needle, and injected into the medial and lateral pre-tarsal orbicularis oculi of the upper lid and into the lateral pre-tarsal orbicularis oculi of the lower lid. The initial recommended dose is 1.25-2.5U, at 0.05 mL to 0.1 mL volume at each site. The initial effect of Liztox 200 Unit is generally seen 3 days after being injected. Full effects are seen 1 to 2 weeks after injection. The effects last approximately 3 months. If the initial treatment is deemed insufficient (i.e. effects do not last longer than 2 months), then the dose can be increased up to two-fold in repeat treatment sessions. However, there seems to be little benefit from injecting more than 5.0 U per injection site. Patients may develop a tolerance if treatments for blepharospasm are administered more frequently than every three months. The cumulative dose of Liztox 200 Unit should not exceed 200 U in a 30-day period.
To address the masseter(jaw) muscle: Before getting the injections, it is important to have a consultation with a medical professional that will examine the jaw and face area to determine the injection site. A medical professional will clean the skin before the injection to reduce the risk of infection. A topical anesthesia to numb the area may be used. Next, the doctor will insert the thin needle into the masseter muscle. After the procedure is completed and the toxin is injected, the needle will be slowly withdrawn. The procedure may be repeated on the other side of the face.
It is important to AVOID rubbing and placing pressure on the treated area for 24 hours.
To treat neck wrinkles: During the injection into the neck area, it is important to contract and relax the platysma muscle multiple times, in order to let the doctor evaluate and select the right area that needs the injections. With the contraction of the muscle, the lines are more visible, and the doctor can grab the muscle and inject botulinum toxin into it. As botulinum toxin weakens the muscles, the motion of the platysma muscle becomes very limited, thanks to that the neck looks smoother by softening the wrinkles and lines. Moreover, as there are no involuntary contractions, the neck appears tighter as well, indirectly improving the appearance of jowls and jawline too.
To administer as skin botox: Skin botox is created by mixing 4 to 5 times more saline solution than the traditional dilution ratio for botulinum toxin procedures. This dilutes the toxin more thinly. The diluted solution should be administered into the dermal layer (skin), which is different from the traditional technique, which administers the toxin solution into the muscle. Skin botox should be injected in small amounts in several small increments in facial areas. Effects of skin botox include the tightening of pores, the reduction of fine lines, the reduced production of oil and sweat, and overall smoother appearance of skin.
Precautions when using Liztox 200 U
Liztox 200 U should be discarded as medical waste once it has passed the expiration date. If the toxin needs to be deactivated (e.g. when spilled out), use diluted hypochlorite(0.5% or 1%) before discarding it as medical waste. Also, products that have come in direct contact with Liztox 200 U should also be discarded as medical waste.
Liztox 200 U is not recommended to be injected frequently. Frequency should not exceed one treatment every 3 months.
The recommended dosage, frequency of treatment, and administration methods of Liztox 200 U should be strictly followed. Certified professionals administering Liztox 200 U should fully understand the relevant neuromuscular and/or orbital anatomy of the treatment area, and also any alterations to the anatomy that have occurred due to prior surgical procedures. DO NOT use Liztox 200 Unit without a doctor’s prescription.
Lixtox 200 Unit and its effects may unintentionally spread and affect other areas and cause adverse symptoms. Symptoms may include asthenia, generalized muscle weakness, dysphonia, dysarthria, stuttering, urinary incontinence, breathing difficulties, dysphagia (swallowing difficulties), diplopia, blurred vision, and ptosis.
The following people SHOULD NOT receive Liztox 200 Unit:
- Patients who have an allergic or hypersensitive reaction to the ingredients in this product
- Patients with neuromuscular junction disorders (dysfunction at location where nerves connect with muscles), including Myasthenia gravis, Lambert-Eaton syndrome, Amyotrophic lateral sclerosis. Using this product causes relaxation of the muscle, which can exacerbate the existing disorder.
- Patients who are pregnant, planning to get pregnant, or are currently nursing mothers
- Patients below the age of 16
Whis is Liztox 200 Unit recommended?
As Liztox 200 Unit is manufactured by one of the largest pharmaceutical companies, Huons Global Co., Ltd., Liztox 200 Unit is recommended to clients who want to use a reliable korean toxin product from a well-known company. Liztox 200 Unit’s quality is truly guaranteed as it has high levels of purity at 99.8%. As such, Liztox 200 Unit is safe to use with minimal side effects.
※ Caution
We, Medi-Fella Korea, do NOT take any responsibility for medical issues and problems that occur during cosmetic procedures.
Liztox 200U
Liztox® is an innovative myorelaxant from the largest South Korean pharmaceutical concern, Huons Global Co., Ltd. The type A botulinum toxin in the product composition provides effective skin flattering through the smoothing of middle-to-deep wrinkles. High degree of product purification promotes fast metabolism of compounds in the body and the aesthetic effect of injections comes to the utmost short term.
Liztox® is a highly-purified clostridium botulinum toxin type A for correction and preventive care of mimic wrinkles. Due to inhibition of signaling between muscles and motor nerves, the product acts as a myorelaxant and is used for the control of dynamic wrinkles. The levelling effect of Liztox is reached by the correction of both, small and deep wrinkles. Applying regularly, the product effectively prevents formation of new folds. In addition, Liztox may be used for the treatment of increased diaphoresis via injections at the perspiratory gland localization (palms, axillas, footsteps). The apparent benefit is the local effect of the drug at the injection area that allows to correct cosmetical defects or provide a treatment (at hyperhydrosis) pointwise, without any side effects on the whole body.
Liztox® 200U benefits:
- high degree of product purification (99.8%),
- very quickly metabolized by the body, so the effect is visible even 3-7 days after the treatment,
- product safety which eliminates side effects,
- using the micro-papule technique, the product can be used to correct mimic wrinkles around the mouth.
How to administer Liztox 200 U
To address glabellar lines (forehead wrinkles): Using a 30 gauge needle, inject the dissolved product in the corrugator muscles and the procerus muscle (a total of 5 areas). 0.1ml of the product should be injected in each area, with a total of 20 U being injected.
When injecting into the inner corrugator supercilii muscle and the medial eyebrows, inject at least 1 cm from the edge of the eye. During injection, the needle should be aimed at the upper center, and the injection volume should be accurate. Careful attention should be paid to NOT inject Liztox 200 U into the blood vessel. To prevent Liztox 200 U from being injected into the blood vessel(exudation) below the orbital ridge, place the thumb or index finger below the orbital ridge prior to injection.
The corrugator muscle and the orbicularis oculi muscle move in the middle of the forehead to make glabellar folds on the face. The procerus muscle and the depressor supercilii muscle pull the forehead downward. These muscles create frown lines or wrinkles. Because the muscle position, muscle size, and use of muscle vary from person to person, the effective dose is determined by complete observation of the patient's ability to control the implanted surface muscles.
To address wrinkles around the eyes: Using a 30~33 gauge needle, administer 0.1ml(4U) each on 3 areas on one of the outer regions of the orbicularis oculi muscles (6 areas on both sides, total of 24 U).
To treat blepharospasm: Blepharospasm is defined as the uncontrollable muscle movements of the eyelid. Liztox 200 Unit should be administered using a sterile, 27-30 gauge needle, and injected into the medial and lateral pre-tarsal orbicularis oculi of the upper lid and into the lateral pre-tarsal orbicularis oculi of the lower lid. The initial recommended dose is 1.25-2.5U, at 0.05 mL to 0.1 mL volume at each site. The initial effect of Liztox 200 Unit is generally seen 3 days after being injected. Full effects are seen 1 to 2 weeks after injection. The effects last approximately 3 months. If the initial treatment is deemed insufficient (i.e. effects do not last longer than 2 months), then the dose can be increased up to two-fold in repeat treatment sessions. However, there seems to be little benefit from injecting more than 5.0 U per injection site. Patients may develop a tolerance if treatments for blepharospasm are administered more frequently than every three months. The cumulative dose of Liztox 200 Unit should not exceed 200 U in a 30-day period.
To address the masseter(jaw) muscle: Before getting the injections, it is important to have a consultation with a medical professional that will examine the jaw and face area to determine the injection site. A medical professional will clean the skin before the injection to reduce the risk of infection. A topical anesthesia to numb the area may be used. Next, the doctor will insert the thin needle into the masseter muscle. After the procedure is completed and the toxin is injected, the needle will be slowly withdrawn. The procedure may be repeated on the other side of the face.
It is important to AVOID rubbing and placing pressure on the treated area for 24 hours.
To treat neck wrinkles: During the injection into the neck area, it is important to contract and relax the platysma muscle multiple times, in order to let the doctor evaluate and select the right area that needs the injections. With the contraction of the muscle, the lines are more visible, and the doctor can grab the muscle and inject botulinum toxin into it. As botulinum toxin weakens the muscles, the motion of the platysma muscle becomes very limited, thanks to that the neck looks smoother by softening the wrinkles and lines. Moreover, as there are no involuntary contractions, the neck appears tighter as well, indirectly improving the appearance of jowls and jawline too.
To administer as skin botox: Skin botox is created by mixing 4 to 5 times more saline solution than the traditional dilution ratio for botulinum toxin procedures. This dilutes the toxin more thinly. The diluted solution should be administered into the dermal layer (skin), which is different from the traditional technique, which administers the toxin solution into the muscle. Skin botox should be injected in small amounts in several small increments in facial areas. Effects of skin botox include the tightening of pores, the reduction of fine lines, the reduced production of oil and sweat, and overall smoother appearance of skin.
Precautions when using Liztox 200 U
Liztox 200 U should be discarded as medical waste once it has passed the expiration date. If the toxin needs to be deactivated (e.g. when spilled out), use diluted hypochlorite(0.5% or 1%) before discarding it as medical waste. Also, products that have come in direct contact with Liztox 200 U should also be discarded as medical waste.
Liztox 200 U is not recommended to be injected frequently. Frequency should not exceed one treatment every 3 months.
The recommended dosage, frequency of treatment, and administration methods of Liztox 200 U should be strictly followed. Certified professionals administering Liztox 200 U should fully understand the relevant neuromuscular and/or orbital anatomy of the treatment area, and also any alterations to the anatomy that have occurred due to prior surgical procedures. DO NOT use Liztox 200 Unit without a doctor’s prescription.
Lixtox 200 Unit and its effects may unintentionally spread and affect other areas and cause adverse symptoms. Symptoms may include asthenia, generalized muscle weakness, dysphonia, dysarthria, stuttering, urinary incontinence, breathing difficulties, dysphagia (swallowing difficulties), diplopia, blurred vision, and ptosis.
The following people SHOULD NOT receive Liztox 200 Unit:
- Patients who have an allergic or hypersensitive reaction to the ingredients in this product
- Patients with neuromuscular junction disorders (dysfunction at location where nerves connect with muscles), including Myasthenia gravis, Lambert-Eaton syndrome, Amyotrophic lateral sclerosis. Using this product causes relaxation of the muscle, which can exacerbate the existing disorder.
- Patients who are pregnant, planning to get pregnant, or are currently nursing mothers
- Patients below the age of 16
Whis is Liztox 200 Unit recommended?
As Liztox 200 Unit is manufactured by one of the largest pharmaceutical companies, Huons Global Co., Ltd., Liztox 200 Unit is recommended to clients who want to use a reliable korean toxin product from a well-known company. Liztox 200 Unit’s quality is truly guaranteed as it has high levels of purity at 99.8%. As such, Liztox 200 Unit is safe to use with minimal side effects.
※ Caution
We, Medi-Fella Korea, do NOT take any responsibility for medical issues and problems that occur during cosmetic procedures.